Histogen Inc (HSTO)
0.3501
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Histogen Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2021 | 30.82% |
| December 31, 2020 | 38.08% |
| September 30, 2020 | 34.34% |
| June 30, 2020 | 17.59% |
| Date | Value |
|---|---|
| March 31, 2020 | 73.62% |
| December 31, 2019 | 29.21% |
| September 30, 2019 | 41.08% |
| June 30, 2019 | 53.88% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
17.59%
Minimum
Jun 2020
73.62%
Maximum
Mar 2020
39.83%
Average
36.21%
Median
Gross Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 81.54% |
| IGC Pharma Inc | 65.20% |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Protalix BioTherapeutics Inc | 15.54% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -107.1% |
| Return on Assets | -80.72% |
| Return on Invested Capital | -117.6% |
| Profit Margin (Quarterly) | -77.02K% |
| Operating Margin (Quarterly) | -70.50K% |
| Return on Net Operating Assets | -296.9% |